2024/02/28 by Heather Whitaker, Beth Findlay, Jana Zitha +28 · 1 voice
Medicine · #Influenza Virus Research Studies #Respiratory Support and Mechanisms #Sepsis Diagnosis and Treatment
paper · pdf · doi:10.1101/2024.02.27.24303426
openalex publication_date 2024/02/28 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/14
Abstract We report 2023/24 season interim influenza vaccine effectiveness for three studies, including primary care in Great Britain, hospital settings in Scotland and hospital settings in England. Adjusted vaccine effectiveness against all influenzas ranged from 63% (46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.